Vaccine composition for preventing human infection of SARS coronavirus and alleviating infection symptoms
AssigneeLibentech Co., Ltd.
InventorsHyun Jang, Bo-Kyoung Jung, Yong-Hee An
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a vaccine composition for preventing human infection SARS-CoV-2 (COVID-19) and alleviating infection symptoms, and the vaccine composition including a recombinant Newcastle disease virus on the surface of which the SARS-CoV-2 RBD protein of the present disclosure is expressed or antigen purified therefrom induces an immune response that can fight COVID-19 infection so that it can be useful as a vaccine for preventing and treating SARS-CoV-2 infection.
Claims19
A vector for insertion of a foreign gene, comprising Newcastle disease virus cDNA including genes encoding NP, P, M, F, HN and L proteins and a transgene cassette,
- wherein the transgene cassette includes a sequence of Gene start (GS)-Intergenic sequence (IG)-Gene end (GE)) and MCS (multicloning site),
- wherein the vector is SEQ ID NO:
- 1.
Dependencies are inferred from the claim text.